Cargando…

CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer

Anaplastic carcinoma of the thyroid (ATC), also called undifferentiated thyroid cancer, is the least common but most aggressive and deadly thyroid gland malignancy of all thyroid cancers. The aim of this study is to explore essential biomarker and use CRISPR/Cas9 with lentivirus delivery to establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Li-Chi, Tam, Ka-Wai, Liu, Wei-Ni, Lin, Chun-Yu, Hsu, Kai-Wen, Hsieh, Wen-Shyang, Chi, Wei-Ming, Lee, Ai-Wei, Yang, Jinn-Moon, Lin, Ching-Ling, Lee, Chia-Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925145/ https://www.ncbi.nlm.nih.gov/pubmed/29849821 http://dx.doi.org/10.1155/2018/3835783

Ejemplares similares

ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
por: Chen, Shu-Huey, et al.
Publicado: (2020)

CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
por: Zhang, Wen-Wei, et al.
Publicado: (2015)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Off-target predictions in CRISPR-Cas9 gene editing using deep learning
por: Lin, Jiecong, et al.
Publicado: (2018)

Protoplasts: From Isolation to CRISPR/Cas Genome Editing Application
por: Yue, Jin-Jun, et al.
Publicado: (2021)

Enhancing the Heterologous Fructosyltransferase Activity of Kluyveromyces lactis: Developing a Scaled-Up Process and Abolishing Invertase by CRISPR/Cas9 Genome Editing
por: Burghardt, Jan Philipp, et al.
Publicado: (2020)

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
por: Feng, Yan, et al.
Publicado: (2016)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Computational Tools and Resources for CRISPR/Cas Genome Editing
por: Li, Chao, et al.
Publicado: (2023)

A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
por: Sinha, Sanju, et al.
Publicado: (2021)

Heritable Genome Editing with CRISPR/Cas9 in the Silkworm, Bombyx mori
por: Wei, Wei, et al.
Publicado: (2014)

Optimization of CRISPR/Cas9 genome editing in cotton by improved sgRNA expression
por: Long, Lu, et al.
Publicado: (2018)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
por: Maddalo, Danilo, et al.
Publicado: (2014)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
por: Li, Fan, et al.
Publicado: (2020)

HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
por: Lao, Yeh‐Hsing, et al.
Publicado: (2018)

Outbred genome sequencing and CRISPR/Cas9 gene editing in butterflies
por: Li, Xueyan, et al.
Publicado: (2015)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing
por: Yang, Haitao, et al.
Publicado: (2018)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
por: Chuang, Yu-Fan, et al.
Publicado: (2021)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing
por: Liu, Yunkun, et al.
Publicado: (2015)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
por: Sinha, Sanju, et al.
Publicado: (2022)

Efficient multiplex genome editing by CRISPR/Cas9 in common wheat
por: Li, Jihu, et al.
Publicado: (2020)

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
por: Zhang, Huimin, et al.
Publicado: (2021)

Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system
por: Zhang, Yihan, et al.
Publicado: (2017)

CRISPR/Cas9 mediated mutation of mouse IL-1α nuclear localisation sequence abolishes expression
por: Daniels, Michael J. D., et al.
Publicado: (2017)

Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing
por: Fu, Ya-Wen, et al.
Publicado: (2021)

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics
por: Liu, Wenyi, et al.
Publicado: (2021)

Efficient genome editing in plants using a CRISPR/Cas system
por: Feng, Zhengyan, et al.
Publicado: (2013)

Phylogenetic Distribution of CRISPR-Cas Systems in Staphylococcus lugdunensis
por: Kao, Cheng-Yen, et al.
Publicado: (2021)

CRISPR/Cas9-mediated genome editing in vancomycin-producing strain Amycolatopsis keratiniphila
por: Hu, Mengyi, et al.
Publicado: (2023)

Efficient CRISPR–Cas9 mediated multiplex genome editing in yeasts
por: Wang, Laiyou, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pih56jo4q1u9sdfcojnqrh4v6a